126 related articles for article (PubMed ID: 38384049)
21. Pancytokeratin immunostained tumor buds and cytoplasmic pseudofragments are reliable early predictive variables for regional lymph node metastatic risk assessment of oral squamous cell carcinoma.
Sowmya SV; Rao RS; Prasad K
Indian J Dent Res; 2020; 31(6):904-910. PubMed ID: 33753662
[TBL] [Abstract][Full Text] [Related]
22. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
[TBL] [Abstract][Full Text] [Related]
23. Upregulated circ_0002141 facilitates oral squamous cell carcinoma progression via the miR-1231/EGFR axis.
Wangzhou K; Lu Z; Lai Z; Fu W; Liu C; Tan Y; Hao C
Oral Dis; 2023 Apr; 29(3):902-912. PubMed ID: 34739167
[TBL] [Abstract][Full Text] [Related]
24. Clinical implications of heat shock protein 70 in oral carcinogenesis and prediction of progression and recurrence in oral squamous cell carcinoma patients: a retrospective clinicopathological study.
Elhendawy HA
Eur J Med Res; 2023 Oct; 28(1):464. PubMed ID: 37884988
[TBL] [Abstract][Full Text] [Related]
25. Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma.
Keller J; Nimnual AS; Shroyer KR; Joy C; Ischenko I; Chandler CS; Dong LM; Hayman MJ; Chan EL
Br J Cancer; 2013 Jul; 109(2):482-92. PubMed ID: 23799848
[TBL] [Abstract][Full Text] [Related]
26. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871
[TBL] [Abstract][Full Text] [Related]
28. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
[TBL] [Abstract][Full Text] [Related]
30. IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling.
Pidugu VK; Wu MM; Yen AH; Pidugu HB; Chang KW; Liu CJ; Lee TC
Oncogene; 2019 Apr; 38(17):3232-3247. PubMed ID: 30626937
[TBL] [Abstract][Full Text] [Related]
31. pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: a tissue-microarray study with clinic-pathological correlations.
Aquino G; Pannone G; Santoro A; Liguori G; Franco R; Serpico R; Florio G; De Rosa A; Mattoni M; Cozza V; Botti G; Losito S; Longo F; Staibano S; Cuda G; Lo Muzio L; Sbordone C; Bufo P; Grimaldi A; Caraglia M; Di Domenico M
Cancer Biol Ther; 2012 Sep; 13(11):967-77. PubMed ID: 22825335
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas.
Hiraishi Y; Wada T; Nakatani K; Negoro K; Fujita S
Pathol Oncol Res; 2006; 12(2):87-91. PubMed ID: 16799709
[TBL] [Abstract][Full Text] [Related]
33. Nimotuzumab increases the anti-tumor effect of photodynamic therapy in an oral tumor model.
Bhuvaneswari R; Ng QF; Thong PS; Soo KC
Oncotarget; 2015 May; 6(15):13487-505. PubMed ID: 25918252
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma.
Tan DSW; Chong FT; Leong HS; Toh SY; Lau DP; Kwang XL; Zhang X; Sundaram GM; Tan GS; Chang MM; Chua BT; Lim WT; Tan EH; Ang MK; Lim TKH; Sampath P; Chowbay B; Skanderup AJ; DasGupta R; Iyer NG
Nat Med; 2017 Oct; 23(10):1167-1175. PubMed ID: 28920960
[TBL] [Abstract][Full Text] [Related]
35. In-vivo imaging of oral squamous cell carcinoma by EGFR monoclonal antibody conjugated near-infrared quantum dots in mice.
Yang K; Zhang FJ; Tang H; Zhao C; Cao YA; Lv XQ; Chen D; Li YD
Int J Nanomedicine; 2011; 6():1739-45. PubMed ID: 21980236
[TBL] [Abstract][Full Text] [Related]
36. Prognostic evaluation of tumour budding in oral squamous cell carcinoma: Evidenced by CD44 expression as a cancer stem cell marker.
Niranjan KC; Raj M; Hallikeri K
Pathol Res Pract; 2023 Nov; 251():154883. PubMed ID: 37898041
[TBL] [Abstract][Full Text] [Related]
37. Hsa_circ_0005379 regulates malignant behavior of oral squamous cell carcinoma through the EGFR pathway.
Su W; Wang Y; Wang F; Sun S; Li M; Shen Y; Yang H
BMC Cancer; 2019 Apr; 19(1):400. PubMed ID: 31035951
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic Effects of Perilla Phenols in Oral Squamous Cell Carcinoma.
Lee CH; Tsao YH; Weng YP; Wang IC; Chen YP; Hung PF
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834377
[TBL] [Abstract][Full Text] [Related]
39. Epidermal Growth Factor (EGF) Autocrine Activation of Human Platelets Promotes EGF Receptor-Dependent Oral Squamous Cell Carcinoma Invasion, Migration, and Epithelial Mesenchymal Transition.
Chen R; Jin G; Li W; McIntyre TM
J Immunol; 2018 Oct; 201(7):2154-2164. PubMed ID: 30150285
[TBL] [Abstract][Full Text] [Related]
40. GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity.
Lin MC; Huang MJ; Liu CH; Yang TL; Huang MC
Oral Oncol; 2014 May; 50(5):478-84. PubMed ID: 24582885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
